Chronic obstructive pulmonary disease (COPD)
618 results
101 - 200
Vitamin D for the management of chronic obstructive pulmonary disease
Guidelines for COPD (ACP)- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
- Proton pump inhibitors for chronic obstructive pulmonary disease
- Bisoprolol does not reduce exacerbations in adults with chronic obstructive pulmonary disease (BICS)
- Summary of GOLD guideline for COPD
- Guidelines for the management of COPD
- Smoking cessation for chronic obstructive pulmonary disease
- Tiotropium for stable chronic obstructive pulmonary disease
Hyperventilation - Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
- Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
- Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
- Domiciliary oxygen for chronic obstructive pulmonary disease
- Corticosteroids benefit patients with moderate to severe COPD
- Inhaled budesonide for COPD not associated with pneumonia
- Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
- Curable causes of cognitive challenges and memory disease
- Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
- Oral = IV prednisolone for COPD exacerbation
- Improved outcomes with azithromycin vs beta-lactams for acute exacerbations of chronic obstructive pulmonary disease
- In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
- Uncertain benefit of home noninvasive positive pressure ventilation for adults with chronic obstructive pulmonary disease
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Self-management teaching not helpful for COPD
- Inhaled steroids only decrease COPD exacerbations slightly
- Breathing exercises for chronic obstructive pulmonary disease: Cochrane systematic review
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
- Breathing exercises for chronic obstructive pulmonary disease
- Antibiotic and corticosteroid treatment effective for acute exacerbations of COPD
- Anticholinergics of greater benefit in COPD treatment
- Physician assessment of COPD doesn't match spirometry results
- Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
- Telehealthcare for chronic obstructive pulmonary disease
- USPSTF: D recommendation against screening for COPD in asymptomatic adults
- Inhaled corticosteroids increase pneumonia risk in stable COPD
- Corticosteroids, selective use of antibiotics and NPPV for COPD exacerbations
- Tiotropium mist associated with mortality in COPD treatment
- Azithromycin of questionable benefit given daily for COPD
- Fluticasone plus vilanterol an option for COPD
- Long-term erythromycin decreases COPD exacerbations
- Simple risk score predicts severity of COPD exacerbations
- American Thoracic Society home oxygen guideline for patients with COPD or interstitial lung disease
- 3-in-1 inhaler for chronic obstructive pulmonary disease may provide better outcomes than multiple individual inhalers (SKOPOS-MAZI)
- Smoking cessation for people with chronic obstructive pulmonary disease
- Supplemental oxygen ineffective for COPD with moderate hypoxemia
- Inhaled steroids for COPD associated with increased risk of pneumonia
- Tiotropium not associated with increase cardiovascular risk in patients with COPD
- Long-acting bronchodilators similarly safe in COPD patients
- Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
- Home care by outreach nursing for chronic obstructive pulmonary disease
- Pneumococcal vaccines for patients with chronic obstructive pulmonary disease
- Procalcitonin test can reduce antibiotic use in COPD
- Dyspnoea
- Singing for adults with chronic obstructive pulmonary disease
- For mild to severe COPD exacerbations, antibiotics and steroids remain the mainstay of treatment
- Sputum purulence and CRP predict poor prognosis with COPD exacerbation
- 5-day steroid treatment effective for acute COPD exacerbation
- Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Tiotropium versus placebo for chronic obstructive pulmonary disease
- Inhaled anticholinergics associated with increased risk of CVD in COPD
- Fluticasone + salmeterol may reduce mortality but also increase pneumonia in COPD
- Salmeterol + fluticasone better than tiotropium in COPD (INSPIRE)
- COPD -- combo therapy improves symptoms but doesn't decrease exacerbations
- Better outcomes with noninvasive ventilation for hospitalized COPD patients
- Reduced readmissions with home NIV plus oxygen for COPD exacerbation with persistent hypercapnia
- Acute bronchitis
- Helium-oxygen improves exercise tolerance in pts with COPD
- Chronic non‐invasive ventilation for chronic obstructive pulmonary disease
- No change in duration of mechanical ventilation with acetazolamide for COPD patients with metabolic alkalosis
- Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
- Pressurised metered‐dose inhalers versus all other hand‐held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
- High-efficiency air cleaners decrease exacerbations and the use of rescue medication in former smokers with COPD
- Short-course antibiotics effective for acute exacerbation of COPD
- Self-management training, routine monitoring not effective for COPD
- DECAF score provides accurate prognosis for patients with acute exacerbation of COPD
- Low-dose theophylline is minimally helpful, if at all, in preventing COPD exacerbations
- Amox-clavulanate during COPD exacerbations decreases Sx and delays subsequent exacerbations
- Beta-blockers associated with improved morbidity/mortality in COPD patients
- Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD
- Tiotropium via Soft Mist Inhaler increases all-cause mortality in COPD